Eledon Pharmaceuticals (ELDN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.13, -6.17% vs the prior close of $2.27.
- Volume 783.41K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELDN slides 6.2% to $2.13, a 6-month low. Closed at $2.13, -6.17% vs the prior close of $2.27. Day range $2.13–$2.42, opened at $2.27.
ELDN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ELDN slides 6.2% to $2.13, a 6-month low
- Closed at $2.13, -6.17% vs the prior close of $2.27. Day range $2.13–$2.42, opened at $2.27.
- Volume was 783.41K shares, 0.9x its 50-day average of 889.82K.
- Price is -27.1% vs its 50-day average ($2.92) and -30.7% vs its 200-day average ($3.07).
- 52-week range $1.35–$4.60; today's close sits at 24% of that range, 53.7% below the 52-week high.
Oct 15, 2026 — ELDN rises 0.9% to $2.27
- Closed at $2.27, +0.89% vs the prior close of $2.25. Day range $2.21–$2.35, opened at $2.25.
- Volume was 581.90K shares, 0.7x its 50-day average of 893.60K.
- Price is -23.1% vs its 50-day average ($2.95) and -26.0% vs its 200-day average ($3.07).
- 52-week range $1.35–$4.60; today's close sits at 28% of that range, 50.7% below the 52-week high.
Oct 14, 2026 — ELDN slides 3.8% to $2.25, a 6-month low, 3 down days in a row
- Closed at $2.25, -3.85% vs the prior close of $2.34. Day range $2.22–$2.36, opened at $2.31.
- Volume was 987.30K shares, 1.1x its 50-day average of 889.96K.
- Price is -24.3% vs its 50-day average ($2.97) and -26.6% vs its 200-day average ($3.06).
- 52-week range $1.35–$4.60; today's close sits at 28% of that range, 51.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ELDN slides 4.1% to $2.34, a 6-month low
- Closed at $2.34, -4.10% vs the prior close of $2.44. Day range $2.32–$2.49, opened at $2.49.
- Volume was 1.17M shares, 1.3x its 50-day average of 898.63K.
- Price is -22.0% vs its 50-day average ($3.00) and -23.6% vs its 200-day average ($3.06).
- 52-week range $1.35–$4.60; today's close sits at 30% of that range, 49.1% below the 52-week high.
Oct 12, 2026 — ELDN dips 1.6% to $2.44
- Closed at $2.44, -1.61% vs the prior close of $2.48. Day range $2.42–$2.58, opened at $2.50.
- Volume was 440.50K shares, 0.5x its 50-day average of 902.66K — lighter than usual.
- Price is -19.2% vs its 50-day average ($3.02) and -20.2% vs its 200-day average ($3.06).
- 52-week range $1.35–$4.60; today's close sits at 34% of that range, 47.0% below the 52-week high.
Oct 9, 2026 — ELDN rises 2.5% to $2.48
- Closed at $2.48, +2.48% vs the prior close of $2.42. Day range $2.42–$2.56, opened at $2.42.
- Volume was 818.70K shares, 0.9x its 50-day average of 907.87K.
- Price is -18.4% vs its 50-day average ($3.04) and -18.8% vs its 200-day average ($3.05).
- 52-week range $1.35–$4.60; today's close sits at 35% of that range, 46.1% below the 52-week high.
Oct 8, 2026 — ELDN ends flat (+0.0%) to $2.42, 3 down days in a row
- Closed at $2.42, +0.00% vs the prior close of $2.42. Day range $2.36–$2.44, opened at $2.40.
- Volume was 834.50K shares, 0.9x its 50-day average of 912.76K.
- Price is -20.9% vs its 50-day average ($3.06) and -20.6% vs its 200-day average ($3.05).
- 52-week range $1.35–$4.60; today's close sits at 33% of that range, 47.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ELDN dips 1.2% to $2.42, a 6-month low
- Closed at $2.42, -1.22% vs the prior close of $2.45. Day range $2.39–$2.48, opened at $2.42.
- Volume was 583.40K shares, 0.6x its 50-day average of 931.50K.
- Price is -21.3% vs its 50-day average ($3.08) and -20.5% vs its 200-day average ($3.05).
- 52-week range $1.35–$4.60; today's close sits at 33% of that range, 47.4% below the 52-week high.
Oct 6, 2026 — ELDN dips 2.0% to $2.45
- Closed at $2.45, -2.00% vs the prior close of $2.50. Day range $2.42–$2.56, opened at $2.53.
- Volume was 828.00K shares, 0.9x its 50-day average of 946.43K.
- Price is -20.8% vs its 50-day average ($3.10) and -19.4% vs its 200-day average ($3.04).
- 52-week range $1.35–$4.60; today's close sits at 34% of that range, 46.7% below the 52-week high.
Oct 5, 2026 — ELDN rises 0.4% to $2.50
- Closed at $2.50, +0.40% vs the prior close of $2.49. Day range $2.45–$2.57, opened at $2.53.
- Volume was 720.20K shares, 0.8x its 50-day average of 957.63K.
- Price is -19.8% vs its 50-day average ($3.12) and -17.7% vs its 200-day average ($3.04).
- 52-week range $1.35–$4.60; today's close sits at 35% of that range, 45.7% below the 52-week high.
Oct 2, 2026 — ELDN rises 2.3% to $2.49
- Closed at $2.49, +2.26% vs the prior close of $2.43. Day range $2.42–$2.55, opened at $2.48.
- Volume was 967.20K shares, 1.0x its 50-day average of 950.62K.
- Price is -20.7% vs its 50-day average ($3.14) and -17.9% vs its 200-day average ($3.03).
- 52-week range $1.35–$4.60; today's close sits at 35% of that range, 45.9% below the 52-week high.
ELDN latest news & SEC filings
Every SEC filing by or about ELDN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 4, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$31.63M (prior year -$11.22M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.27 (prior year -$0.13) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ELDN
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 19, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.71% (largest 7.4%).
- Liquidity: about 856.74K shares (≈$1.82M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.13 vs a range of $1.35–$4.60 (24% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Jun 22, 2026.
- Share count: 81.26M shares outstanding (Aug 10, 2026), +35.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ELDN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.27 | 2.42 | 2.13 | 2.13 | 783.41K |
| Oct 15, 2026 | 2.25 | 2.35 | 2.21 | 2.27 | 581.90K |
| Oct 14, 2026 | 2.31 | 2.36 | 2.22 | 2.25 | 987.30K |
| Oct 13, 2026 | 2.49 | 2.49 | 2.32 | 2.34 | 1.17M |
| Oct 12, 2026 | 2.50 | 2.58 | 2.42 | 2.44 | 440.50K |
| Oct 9, 2026 | 2.42 | 2.56 | 2.42 | 2.48 | 818.70K |
| Oct 8, 2026 | 2.40 | 2.44 | 2.36 | 2.42 | 834.50K |
| Oct 7, 2026 | 2.42 | 2.48 | 2.39 | 2.42 | 583.40K |
| Oct 6, 2026 | 2.53 | 2.56 | 2.42 | 2.45 | 828.00K |
| Oct 5, 2026 | 2.53 | 2.57 | 2.45 | 2.50 | 720.20K |
| Oct 2, 2026 | 2.48 | 2.55 | 2.42 | 2.49 | 967.20K |
| Oct 1, 2026 | 2.52 | 2.55 | 2.42 | 2.43 | 616.30K |
| Sep 30, 2026 | 2.53 | 2.62 | 2.50 | 2.53 | 717.40K |
| Sep 29, 2026 | 2.64 | 2.64 | 2.49 | 2.50 | 712.20K |
| Sep 28, 2026 | 2.65 | 2.66 | 2.53 | 2.64 | 714.50K |
| Sep 25, 2026 | 2.68 | 2.68 | 2.62 | 2.65 | 619.80K |
| Sep 24, 2026 | 2.72 | 2.77 | 2.60 | 2.68 | 1.03M |
| Sep 23, 2026 | 2.90 | 2.94 | 2.68 | 2.72 | 1.32M |
| Sep 22, 2026 | 2.75 | 3.09 | 2.68 | 2.89 | 2.09M |
| Sep 21, 2026 | 2.74 | 2.74 | 2.59 | 2.69 | 607.30K |
About Eledon Pharmaceuticals
Eledon Pharmaceuticals (ELDN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1404281.
ELDN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David-Alexandre C Gros | Chief Executive Officer | Aug 4, 2026 |
| Jan Hillson | Director | Jan 16, 2026 |
| Keith Katkin | Director | Jan 16, 2026 |
| Allan Kirk | Director | Jan 16, 2026 |
| June Lee | Director | Jan 16, 2026 |
| John S. Mcbride | Director | Jan 16, 2026 |
| Steven Perrin | President | Aug 4, 2026 |
| James A. Jr. Robinson | Director | Jan 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David-Alexandre C Gros | Chief Executive Officer | Aug 4, 2026 |
| Steven Perrin | President | Aug 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ELDN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-45.62M | -0.52 | $-62.34M |
| Dec 31, 2024 | — | $-36.18M | -0.66 | $-47.27M |
| Dec 31, 2023 | — | $-116.54M | -4.73 | $-39.53M |
| Dec 31, 2022 | — | $-87.97M | -6.16 | $-28.42M |
| Dec 31, 2021 | — | $-34.51M | -2.33 | $-28.91M |
Latest balance sheet: total assets $126.09M, total liabilities $54.06M, cash $6.80M (as of Jun 30, 2026).
ELDN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $3.70 |
| May 13, 2026 | 8-K Item 2.02 (results) | $3.88 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $2.85 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $1.76 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $2.06 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.60 |
| May 14, 2025 | 8-K Item 2.02 (results) | $2.83 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $3.44 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $4.82 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ELDN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.